MedTrace Logo

Healthy Lifestyles for Bipolar Disorder

NCT06188754 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2025-02-06

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the effects of two different healthy lifestyles on outcomes for those with bipolar disorder. The goals are to understand the acceptability of time-restricted eating and the mediterranean diet for those who are already receiving medication treatment for bipolar disorder, and to consider how these two food plans predict changes in manic symptoms, depressive symptoms, and Quality of Life. Participants will complete daily measures of eating, sleep and mood for two weeks, and then will be assigned to follow one of the two food plans for eight weeks. The investigators will measure symptoms and Quality of Life at baseline and during and after the food plan.

Conditions

  • Time Restricted Eating
  • Diet, Mediterranean

Interventions

BEHAVIORAL

Time restricted eating

Limiting food intake to 10 hours per day

BEHAVIORAL

Mediterranean diet

Dietary advice designed to improve consumption of vegetables, fruits, whole grains, and the use of olive oil.

Sponsors & Collaborators

  • University College, London

    collaborator OTHER

  • Swinburne University of Technology

    collaborator OTHER

  • Deakin University

    collaborator OTHER

  • University of British Columbia

    collaborator OTHER

  • Salk Institute for Biological Studies

    collaborator OTHER

  • Wellcome Trust

    collaborator OTHER

  • University of California, Berkeley

    lead OTHER

Principal Investigators

  • Sheri L Johnson, PhD · University of California, Berkeley

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-05
Primary Completion
2028-12-28
Completion
2029-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06188754 on ClinicalTrials.gov